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The equilibrium between gut microbes and secreted mucus
is vital to maintaining intestinal health (1–3). Heavily glycosylated mucus components are produced in abundance by specialized cells in the mammalian intestinal mucosa and act as a
physical and biochemical barrier to protect the mammalian
host from inappropriate interactions at the host-microbe interface in the distal colon and rectum (4 –7). Components of the
outermost “loose” mucus layer are an important source of
nutrition for symbiotic bacteria, which have evolved highly efficient means to digest the carbohydrate chains therein (2, 8).
These carbohydrate chains are often capped with unique 9-carbon-backbone monosaccharides called sialic acids, which protect sialoglycoproteins from the action of exoglycosidases,
some endoglycosidases, and certain proteases (9 –11). Sialic
acids come in many forms, the most common of which is
N-acetylneuraminic acid (Neu5Ac)3 (12). A number of intestinal bacteria (both symbionts and pathogens) express sialidases
(also known as neuraminidases), allowing these bacteria to
remove sialic acids from sialoglycans (13). Bacterial sialidases
have been linked with many strategies and mechanisms for survival or proliferation in the host, including the utilization of
sialic acids or underlying carbohydrates as carbon sources,
interaction/adhesion to underlying carbohydrates, immunomodulatory activities, or to break down mucus, allowing better
access to the epithelial surface underneath.
The modification of sialic acids with O-acetyl esters has long
been implicated as a host adaptation that protects the integrity
of the mucus barrier because of the relative resistance of
O-acetylated sialic acids against sialidases (14 –19). However,
studies have indicated that cell-free supernatants of human and
rodent fecal extracts also contain O-acetyl esterases capable of
acting on O-acetylated sialic acids within glycosidically linked
sialoglycan substrates (17, 20, 21). In fact, similar to sialidases,
sialic acid O-acetyl esterases are widely distributed among
human intestinal bacteria and are often expressed on the bacterial cell surface or secreted into culture medium (18). More
recent studies in members of the oral Bacteroidetes further
implicated O-acetyl esterases in glycan foraging within in the
3

The abbreviations used are: Neu5Ac, N-acetylneuraminic acid; DSS, dextran
sulfate sodium; LB, lysogeny broth; BSM, bovine submaxillary mucin; AUS,
A. ureafaciens sialidase; Neu5Gc, N-glycolylneuraminic acid; GBS, group B
Streptococcus; UC, ulcerative colitis; DMB, 1,2,-diamino 4,5-methylenedioxybenzene dihydrochloride; 4-MU-Sia, 4-methylumbelliferyl-N-acetylneuraminic acid; ANOVA, analysis of variance.
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The gut harbors many symbiotic, commensal, and pathogenic
microbes that break down and metabolize host carbohydrates.
Sialic acids are prominent outermost carbohydrates on host glycoproteins called mucins and protect underlying glycan chains
from enzymatic degradation. Sialidases produced by some
members of the colonic microbiota can promote the expansion
of several potential pathogens (e.g. Clostridium difficile, Salmonella, and Escherichia coli) that do not produce sialidases.
O-Acetyl ester modifications of sialic acids help resist the action
of many sialidases and are present at high levels in the mammalian colon. However, some gut bacteria, in turn, produce sialylate-O-acetylesterases to remove them. Here, we investigated
O-acetyl ester removal and sialic acid degradation by Bacteroidetes sialate-O-acetylesterases and sialidases, respectively,
and subsequent utilization of host sialic acids by both commensal and pathogenic E. coli strains. In vitro foraging studies demonstrated that sialidase-dependent E. coli growth on mucin is
enabled by Bacteroides EstA, a sialate O-acetylesterase acting on
glycosidically linked sialylate-O-acetylesterase substrates, particularly at neutral pH. Biochemical studies suggested that
spontaneous migration of O-acetyl esters on the sialic acid side
chain, which can occur at colonic pH, may serve as a switch
controlling EstA-assisted sialic acid liberation. Specifically,
EstA did not act on O-acetyl esters in their initial 7-position.
However, following migration to the 9-position, glycans with
O-acetyl esters became susceptible to the sequential actions of
bacterial esterases and sialidases. We conclude that EstA specifically unlocks the nutritive potential of 9-O-acetylated mucus
sialic acids for foraging by bacteria that otherwise are prevented
from accessing this carbon source.

EstA-mediated sialic acid cross-feeding
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O-acetyl esterase in removing O-acetyl esters of mucin sialic
acids to stimulate cross-species utilization of sialic acids, and 3)
the role of O-acetyl placement and migration in the susceptibility of sialic acid O-acetyl esters to digestion by O-acetyl
esterase.

Results
Members of the genus Bacteroides are an important contributor of bacterial sialidases (13, 18, 31, 39, 40) and sialic acid
O-acetyl esterases (18, 39) relevant to the colonic niche. Thus,
sialidases from Bacteroides fragilis (WP_010992682) and
Bacteroides thetaiotaomicron (WP_008766031) were cloned,
expressed in E. coli, and purified for use in our in vitro models of
cooperative metabolism. Notably, whereas B. fragilis has been
previously shown to utilize its sialidase in the acquisition of
sialic acid, B. thetaiotaomicron does not have a sialic acid catabolic gene cluster and does not utilize the sialic acid it liberates
(41). In contrast, E. coli encodes a pathway for the transport and
catabolism of sialic acid and has been shown to utilize sialic acid
as a carbon source (42). Although some strains of E. coli have
been noted to encode open reading frames annotated as sialidases (13, 43– 45), these are bacteriophage tailspike endosialidases, which degrade the ␣2– 8-linked polysialic acid capsule of
E. coli K1 strains (46). As yet, there have been no functionally
recognized sialidases in E. coli that act on host sialic acids that
are normally found in mucosal contexts.
To directly examine the ability of E. coli (MG1655 (a commensal strain) and EDL933 (an enterohemorrhagic strain)) to
access sialic acids within glycosidically bound sialoglycan substrates, sialic acid levels in cell free supernatants were measured
after overnight growth in lysogeny broth (LB). Briefly, sialic
acids can be measured using a fluorescent derivatization procedure that only works on sialic acids in the free (liberated) monosaccharide form. Thus, we can measure levels of free and total
sialic acids (47) (and by extension, bound sialic acids) in LB by
performing the derivatization with or without prior mild acid
hydrolysis to liberate sialic acids. During routine growth in culture media, sialic acids were mostly found in the bound state
within glycans. These sialic acids within sialoglycans were not
accessible to E. coli (Fig. 1A). In contrast, both strains of E. coli
readily consumed free sialic acid that was added exogenously to
the medium (Fig. 1B). Similarly, the addition of purified sialidases from intestinal bacteria converted bound sialic acids into
“public goods” that could be metabolized by E. coli (Fig. 1C).
We used well described sialidases produced by symbionts,
commensals, and pathogens, including 1) the prevalent gut
symbiont B. thetaiotaomicron (40), 2) the common human
commensal and opportunistic pathogen B. fragilis (48), and 3)
the water-borne bacterial intestinal pathogen Vibrio cholerae
(49). The results of these experiments illustrate that sialidases
known to be present within the context of the healthy gut and
during infection can enable the use of sialic acids by other members of the community. These experiments also demonstrate
the suitability of E. coli as a model organism for investigating
sialic acid scavenging behaviors; it neither expresses sialidase
activity (as shown by the lack of release in Fig. 1A) nor is capable
of accessing sialic acids in bound form without the help of an
accessory sialidase.
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oral mucosa and demonstrated the genetic basis of the enzyme
(22). These examples stand in contrast to other intracellular
bacterial sialic acid O-acetyl esterases that have been shown to
participate in the biosynthesis or catabolism of sialic acids by
acting on free or nucleotide-linked sialic acid esters rather than
complex glycosidically linked substrates (23–25). Finally, we
note that despite the constitutive presence of sialidases and
sialic acid O-acetyl esterases in the large intestine, glycan chains
containing sialic acids and their O-acetylated counterparts are
highly abundant in the distal colon and rectum (26 –29). These
findings suggest that in normal healthy individuals, the rate of
production of mucin sialoglycan chains exceeds the rate of bacterial digestion or that some mucin sialoglycans remain resistant to the action of bacterial enzymes.
The delicate balance of species within gut bacterial communities relies on a web of metabolites produced by individuals or
sectors of the population and consumed by other subsets within
the community. In regards to complex sugars or glycans, it has
been shown that one sector of intestinal bacteria within a population can secrete enzymes that digest these molecules,
whereas another set of organisms can take advantage of this
situation by scavenging the liberated sugars, referred to previously as “public goods” (30). Other recent studies show that this
concept applies to mucus sialic acids and can facilitate the outgrowth of pathogens in the gut (31, 32). For example, one recent
study showed that antibiotic treatment kills sialidase-producing members of the microbiota in the mouse intestine, resulting
in an imbalance in bacterial enzymes and metabolic pathways,
leading to a transient spike in liberated sialic acids. This in turn
supports the metabolism and outgrowth of the antibiotic-associated pathogens Clostridium difficile and Salmonella, which
do not encode sialidases of their own (31). Another recent study
showed that the expansion of certain Bacteroides species during
dextran sulfate sodium (DSS)-induced colitis (a model that
resembles ulcerative colitis) led to similarly increased levels of
sialidase and subsequent outgrowth of Escherichia coli, which
was dependent on the ability of E. coli to catabolize sialic acid
(32) and further exacerbated the colitis. There are in fact many
examples of such bacteria that do not encode sialidases but
have functional (or predicted) sialic acid catabolic pathways.
Another example of sialic acid cross-feeding involves the genus
Bifidobacteria, in which most strains encode the machinery to
catabolize free sialic acid, but a small subset encodes their own
endogenous sialidases (33–38). In short, the cross-species feeding of host sialic acids between members of the gut microbiome
is likely to have broad significance for our understanding of the
microbiota and its role in health and disease.
Based on the very high level of sialic acid O-acetylation in the
distal colon and rectum (26, 29), we hypothesized that the use of
sialic acids as public goods in this niche likely relies on the
action of sialic acid O-acetyl esterases. Here we use in vitro
models to understand the interplay between host O-acetyl
esters and bacterial O-acetylesterases and sialidases, and the
conditions under which these enzymes work together to liberate sialic acids for use by microbes encoding sialic acid catabolic
machinery. Specifically, we investigate 1) the role of sialic acid
O-acetylation as an impediment to the liberation and utilization of sialic acids by intestinal bacteria, 2) the role of bacterial

EstA-mediated sialic acid cross-feeding

To establish the influence of sialic acid O-acetylation on
mobilization of sialic acids from mucin substrates by sialidaseproducing bacteria (B. thetaiotaomicron and B. fragilis), we
used bovine submaxillary mucin (BSM), a “virgin” preparation
of mammalian mucin that is purified directly from the gland,
sparing the mucin from exposure to hydrolases of the microbiota. As such, freshly prepared BSM consists of several percent
sialic acid by weight and contains a high level of sialic acid
O-acetylation. First, BSM was either treated with mild sodium
hydroxide to remove O-acetyl esters or was mock-treated in
parallel prior to sialidase exposure as described under “Experimental procedures.” Fluorescent derivatization of free sialic
acids from the control reactions demonstrated that there was a
very low level of free sialic acid present in samples that were not
exposed to sialidase (Fig. 2A). However, in samples exposed to
sialidases, O-acetylated (mock-treated) mucin sialic acids were
considerably more resistant to the action of sialidases than
NaOH-treated (de-O-acetylated) mucin sialic acids. Thus, consistent with previous studies using different approaches (17, 18,
20), our data show that chemical removal of mucin O-acetyl
esters augments the mobilization of sialic acids by sialidases of
gut bacteria. As previously reported, the sialidase from Arthro-
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Figure 1. E. coli is ill-equipped to catabolize sialic acids in the bound form
but is enabled by accessory sialidases expressed by other intestinal bacteria. Concentration of sialic acid (Neu5Ac) remaining in LB following overnight culture of E. coli (commensal strain MG1655 and enterohemorrhagic
strain EDL933). The figure key showing bound (black bars) and free sialic acid
(white bars) applies to all panels. E. coli was cultured with no added sialidase or
sialic acid (A), 100 M free Neu5Ac added to media (B), or purified His-tagged
B. fragilis or B. thetaiotaomicron sialidase added to media (C) prior to E. coli
inoculation. Similar results were obtained in Columbia media. Another common sialic acid, Neu5Gc, is also liberated by gut sialidases and consumed by
E. coli in this setting. Statistical comparisons (one-way ANOVA followed by
pairwise t tests between the uninoculated control and each experimental
condition, adjusted for multiple comparisons by the Bonferroni method)
were performed using the free sialic acid values. ****, p ⬍ 0.0001 The data
shown are combined from three to five independent experiments, each of
which was performed with one biological replicate and one technical
replicate.

bacter ureafaciens is less sensitive to O-acetylation and is capable of releasing more sialic acid from the mock-treated
(O-acetylated) BSM compared with the Bacteroides sialidases
(Fig. 2A).
The first evidence for the putative genetic basis of B. fragilis
sialic acid O-acetyl esterase activity showed that the enzyme
EstA was capable of producing acetate after incubation with
mucin or with pNP-acetate (39). Next, we directly investigated
the ability of recombinant purified EstA to remove O-acetyl
esters from mucin sialic acids and specifically the O-acetyl
esters of the sialic acid side chain (carbon positions 7 and 9),
resulting in the corresponding non-O-acetylated sialic acid
product. Briefly, EstA was expressed as a 6-histidine-tagged
protein in E. coli and isolated from the periplasmic fraction
with nickel affinity resin as described under “Experimental Procedures.” Expression and purification of EstA-His6 were verified by SDS-PAGE followed by staining with Coomassie Blue
and by Western blotting with anti-His6 monoclonal antibody
(Fig. 2, B and D). BSM was incubated in the presence or absence
of EstA, and product formation was monitored after a 2-h incubation at 37 °C by HPLC of sialic acids released by treatment
with A. ureafaciens sialidase (AUS). In the EstA-treated samples, peaks corresponding to O-acetylated sialic acids disappeared, whereas several species of O-acetylated sialic acids
remained in the mock-treated samples (Fig. 2C). Thus, EstA is
capable of removing O-acetyl esters from the sialic acid side
chain of O-linked mucin glycans.
Sialic acid O-acetyl esterase activity has been previously
described in cell free fecal extracts and is expressed by gut bacterial isolates in both secreted and cell surface forms (17, 18,
20). To determine whether EstA-mediated removal of O-acetyl
esters from mucin sialic acids enables their release by sialidases
of gut bacteria, we treated BSM with sialidases from B. fragilis
and B. thetaiotaomicron in the presence or absence of EstA and
monitored liberation of sialic acid into the free form. These
reactions also modeled the effects of pH on sialic acid liberation
by gut sialidases using conditions that represent the upper and
lower limits of pH in the large intestine (50, 51). As described
under “Experimental procedures,” overall sialic acid release was
followed by base treatment of the samples to collapse all the
sialic acids into two peaks, Neu5Ac and N-glycolylneuraminic
acid (Neu5Gc). This facilitated the accurate quantitation of
sialic acids, which can only be detected in our derivatization
reaction if first liberated. Consistent with previous findings that
many sialidases have optimal activity at somewhat acidic pH,
we found that Bacteroides sialidases liberated significantly less
sialic acid at pH 7.4, a pH more physiologically relevant for the
rectum, than at pH 5.5, which is more relevant to the proximal
colon (compare open bars between pH conditions in Fig. 2,
E–H). Under both pH conditions, the addition of EstA to the
reactions significantly improved the release of sialic acids by gut
bacterial sialidases. This improvement was most striking at a
pH physiologically relevant to the rectum (pH 7.4; Fig. 2, E–H).
Specifically, at pH 5.5, the sialidases released 23–29% more
Neu5Ac (Fig. 2E) and 48 –53% more Neu5Gc (Fig. 2F) in the
presence of EstA, whereas at pH 7.4 the sialidases released
59 –78% more Neu5Ac (Fig. 2G) and 66 – 84% more Neu5Gc
(Fig. 2H) in the presence of EstA. In conclusion, B. fragilis EstA

EstA-mediated sialic acid cross-feeding

hydrolyzes O-acetyl esters from mucin sialic acids in the glycosidically bound form and improves sialic acid liberation by gut
sialidases at the physiologic pH of the colon.
Next, experiments were designed to investigate whether
EstA promotes community foraging of mucin, leading to the
expansion of sialic acid-scavenging bacteria. Here we evaluated
the ability of E. coli to grow in minimal medium supplemented
with mucin as its sole carbon source and the roles of sialidase
and O-acetyl esterase in potentiating sialic acid-dependent
growth. The negative control (E. coli without enzyme addition)
confirms that the bacterium cannot utilize mucin or grow in the
absence of enzymatic assistance from other community members. In contrast, the addition of either B. thetaiotaomicron or
B. fragilis sialidase led to a significant expansion of E. coli (Fig.
3A, dashed lines). Consistent with the increased liberation of
sialic acid in the presence of esterase (Fig. 2), the addition of
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EstA together with sialidase further encourages the proliferation of sialic acid scavenging bacteria (Fig. 3A). In contrast, an
isogenic E. coli strain lacking sialic acid lyase (⌬nanA) was
unable to grow on mucin under these conditions, even in the
presence of sialidase and O-acetylesterase (Fig. 3A, dashed
black line). Studies of certain Bifidobacterium and Bacteroides
species indicate that sialic acid liberation serves the primary
function of unlocking underlying carbohydrates (38, 41, 52).
The fact that the sialate lyase-deficient E. coli strain exhibited
no growth in the presence of sialidase and esterase demonstrates that the bacterial growth observed in these experiments
is solely due to the catabolism of sialic acids. Sialic acids were
significantly depleted by E. coli compared with medium-alone
controls when bacterial sialidases were present (Fig. 3B,
hatched bars), supporting the interpretation that sialic acid foraging is occurring under these conditions. Consistent with the

Downloaded from http://www.jbc.org/ at Washington University on July 29, 2017

Figure 2. The sialic acid O-acetyl esterase EstA augments liberation of mucin sialic acids by sialidases of gut bacteria. BSM treated with and without mild
base was incubated with B. thetaiotaomicron (Bt), B. fragilis (Bf), and A. ureafaciens (Au) sialidases. A, base treatment enhances sialic acid release by sialidases, as
quantified by DMB HPLC. B, expression and purification of B. fragilis EstA-His6. Nickel-purified fractions derived from E. coli expressing EstA-His6 or vector alone
were resolved by SDS-PAGE and stained with Coomassie Blue. C, extended treatment of mucin with B. fragilis esterase results in removal of acetyl groups, as
shown by HPLC traces of DMB-derivatized sialic acids treated with EstA compared with mock-treated control (parallel nickel chromatography of E. coli
periplasm from empty vector-containing E. coli). D, Western blot analysis with monoclonal anti-His6 antibody on fraction 5 of purified EstA-His6 or fraction 5 of
the vector control. E–H, EstA augments sialic acid release from mammalian mucin by B. fragilis (Bf, blue) and B. thetaiotaomicron (Bt, red) NanH sialidases.
Enzyme(s) were incubated with BSM at pH 5.5 (E and F) and pH 7.4 (G and H). Liberated sialic acids were base-treated prior to DMB-HPLC measurement. Neu5Ac
(E and G) and Neu5Gc (F and H) release by each sialidase were measured under each condition. Statistical significance was examined using one-way ANOVA
followed by pairwise t tests adjusted for multiple comparisons by the Bonferroni method. *, p ⬍ 0.05; **, p ⬍ 0.01; ****, p ⬍ 0.0001. The experiment presented
in A was performed three times with one biological replicate and one technical replicate. The experiment shown in C was done four times with two biological
replicates and one technical replicate each. The experiment shown in E–H was performed once with one biological replicate and three technical replicates.
Several iterations were performed at only one pH with similar results.

EstA-mediated sialic acid cross-feeding

enhanced growth observed in experimental groups with both
esterase and sialidase versus those with sialidase alone (Fig. 3A,
dashed versus solid lines), EstA further enhanced the ability of
E. coli to deplete sialic acids from the medium in the presence of
added sialidase (Fig. 3B, solid red and blue bars). Finally, E. coli
was recently shown to use its own intracellular O-acetyl esterase (NanS) to catabolize free 9-O-acetylated sialic acid (25). The
boost in E. coli growth in the presence of B. fragilis EstA compared with sialidase alone strongly supports the conclusion that
extracellular EstA rather than intracellular NanS is responsible
for the sialate lyase-dependent, sialic acid-specific enhancement of growth.
In theory, the removal of sialate esters from either position 7
or 9 would result in Neu5Ac as the reaction product. However,
a clear understanding of enzyme action at these different positions is confounded by the propensity of O-acetyl esters on the
3-carbon sialic acid side chain to migrate. Specifically, sialic
acids O-acetylated at C-7 of sialic acid are prone to pH-dependent (essentially unidirectional) migration along the sialic acid
side chain to C-9 (53–57). However, little is known about the
biological significance of O-acetyl migration, in large part
because of the experimental challenge posed by biological conditions and analytical methods, which often result in extensive
migration and loss of O-acetyl esters (58, 59). Part of the difficulty in interpreting the exact site(s) of action of EstA using
bovine submaxillary mucin as substrate is due to the complexity
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Figure 3. EstA enhances the nutrative potential of mucin during community-driven foraging. E. coli MG1655 was grown in M63 minimal medium
supplemented with bovine submaxillary mucin in the presence of different
enzyme combinations as described under “Experimental procedures.” A,
growth was monitored by optical density (600 nm) readings taken every 2
min using a Tecan M200 plate reader. B, E. coli depletion of mucin sialic acids
was examined by measuring total Neu5Ac levels in spent media at the end of
the growth experiment. ANOVA with Dunnett’s post test was used to examine statistical significance compared with medium alone and E. coli alone
controls: different from media alone (a, black bar), p ⬍ 0.05; different from
E. coli, no enzymes (b, gray bars). One-way ANOVA followed by pairwise t tests
adjusted for multiple comparisons by the Bonferroni method was used to
further evaluate differences between growth under conditions with sialidase
alone versus sialidase ⫹ EstA. *, p ⬍ 0.05. This experiment was performed
once with one biological replicate and one technical replicate and once with
three biological replicates with one technical replicate each. It was also done
as end-point assays in culture tubes, wherein only initial and final optical
density measurements were taken. Bt, red, B. thetaiotaomicron; Bf, blue,
B. fragilis.

of analytical profiles of bovine mucin sialic acids (containing
both Neu5Ac and Neu5Gc, each with multiple O-acetylated
species on the side chain). The problem is compounded by the
notorious lability and migration of O-acetylation on the sialic
acid side chain.
We therefore investigated the role of sialic acid O-acetyl
placement and migration on EstA activity using the simpler
O-acetylated and sialylated capsular polysaccharide of the gut
commensal bacterium group B Streptococcus (GBS) (60). The
GBS capsular polysaccharide mimics mammalian glycan structures and contains O-acetylated sialic acids (57). The advantages of using GBS as an O-acetylesterase substrate are 5-fold:
1) it can be easily cultured to produce high levels of O-acetylation that is freshly added at the 7-carbon position; 2) it allows
the study of glycosidically linked O-acetylated sialic acids without time-consuming substrate isolation steps; 3) it offers a simplified substrate with the major O-acetyl ester in the 7-position,
which can be deliberately migrated to the 9-position for comparison (56); 4) following treatment with EstA, it can be easily
pelleted and washed repeatedly, removing esterase and ensuring that sialic acids released by subsequent sialidase treatment
for HPLC analysis could only have been deacetylated in the
bound condition; and 5) the organism synthesizes only
Neu5Ac, whereas mammalian mucins usually contain mixtures of Neu5Ac and Neu5Gc, each with several sites of
O-acetylation, resulting in a complex pattern of HPLC peaks
that can complicate experimental interpretation. In short, GBS
serves as an excellent model system for investigating EstA activity on O-acetyl esters at C-7 and C-9. We used a strain of GBS
with high levels of O-acetylation resulting from the active site
mutation of an intracellular sialic acid O-acetyl esterase that
GBS itself expresses (23). This strain was chosen for our experiments both because of its high levels of capsular sialic acid
O-acetylation (up to 80% of sialic acids) and because its use
eliminates any possibility that the action of the GBS esterase
might hinder interpretation of the EstA activity assays.
To assess the activity of EstA on 7- and 9-O-acetyl esters, we
combined EstA with preparations of GBS containing these glycosidically linked sialoglycan substrates. In these experiments,
one portion of log phase GBS culture was resuspended in pH 9
Tris buffer and incubated for 30 min at 37 °C to migrate
O-acetyl ester groups to the 9-carbon position. Another portion of culture was kept at neutral pH (in PBS) on ice in parallel,
which retains O-acetyl groups at the 7-carbon position (see
HPLC traces of the 7-O- and 9-O-acetylated starting material
shown in Fig. 4). GBS cells were incubated with purified EstAHis or mock-treated as described under “Experimental procedures.” The assay was performed at a neutral pH relevant to the
distal colon and rectum. The extent and placement of remaining O-acetyl esters was monitored at 0, 30, 90, and 300 min of
incubation. Using 7-O-acetylated sialic acids as substrate, the
EstA- and mock-treated samples experienced a similar net conversion of 7-O-acetyl esters (Fig. 4A). In the mock-treated sample, the progressive loss of O-acetylation at C-7 was accompanied by corresponding increases in the levels of 9-O-acetylated
sialic acid indicative of O-acetyl migration at neutral pH. In
contrast, EstA-treated samples exhibited losses of O-acetylation at C-7 that corresponded with slowly increasing levels of

EstA-mediated sialic acid cross-feeding

unmodified Neu5Ac. When we used 9-O-acetylated sialic acids
as substrate, 9-O-acetyl esters were rapidly and completely
hydrolyzed in the presence of EstA, whereas the mock-treated
sample retained the 9-O-acetyl esters at high levels (Fig. 4B).
These results strongly suggest that 7-O-acetylation is resistant
to the action of the EstA O-acetylesterase, whereas 9-O-acetylation is highly sensitive.

Discussion
The carbohydrates available to microbes in the gut can have
a dramatic influence on the dynamic composition of the microbiota (2, 8, 61– 64). In particular, recent studies show that crossspecies feeding of host sialic acids, made available by the
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secreted sialidases of normal members of the microbiota, can
facilitate intestinal infection and dysbiosis (31, 32). Here we
demonstrate that O-acetylation of host sialic acid limits sialidase liberation of this carbon source for use by sialic acid scavengers. The O-acetylesterase EstA overrides this limitation,
acting under neutral pH conditions relevant to the distal colon
to improve the accessibility of sialic acids to gut bacterial sialidases. We show that EstA mediates cross-species sialic acid
feeding, driving expansion of sialic acid scavengers. Although
the current study is limited to in vitro experiments, our results
are consistent with recent findings in mouse models, which
demonstrate that sialidases produced by the gut microbiota can
liberate sialic acids, which in turn provide a metabolic boost
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Figure 4. EstA acts on 9-O- but not 7-O-acetyl esters of sialic acid. GBS capsular polysaccharide mimics host glycans and can generate high levels of sialic
acid O-acetyl esters that begin at the 7-carbon position and can be migrated to the 9-carbon position. We used the intact capsule on the surface of live GBS as
a model system to define the specificity of EstA. GBS sialic acids that were maintained at the 7-carbon position or induced to migrate to the 9-carbon position
as described under “Experimental procedures” were used as a substrate for purified EstA. After incubation of EstA with GBS bearing 7-O- (A) or 9-O-acetylated
(B) sialic acids in PBS for 30, 90, and 300 min at 37C, bacteria were washed, and their sialic acids were released with A. ureafaciens sialidase and analyzed by
DMB-HPLC. The HPLC traces of mock and EstA-treated samples are from the final, 300-min time point. This experiment was performed twice with one biological
replicate and three technical replicates each.

EstA-mediated sialic acid cross-feeding
integrity of glycan chains against EstA. However, upon migration to the 9-carbon position (9-O-acetylated sialic acid),
the O-acetyl ester becomes susceptible to the action of EstA.
The fact that EstA permits community foraging only after the
O-acetyl group has migrated to C-9 suggests the possibility of
mucin sialic acid “maturation” that protects mucin glycans
immediately after their secretion, when mucins are closest to
the epithelium. Given the published rates of spontaneous 7-Oacetyl ester migration toward the 9-position (53), EstA-susceptible O-acetyl esters at the 9-position would likely be located
exclusively in the aged, outermost mucus layer. This interpretation is supported by both the kinetics of O-acetyl
migration (t1⁄2 of several hours at pH 7.4) (53), as well as the
kinetics of turnover of the inner mucus layer (⬃1 h) (69). The
likelihood that this mechanism contributes to the healthy
host-microbiome interaction is further supported by a recent metagenomic study (comparing twins discordant for
malnutrition phenotypes), which identified sialic acid Oacetylesterase as one of the most significant biomarkers in
the healthy maturation of the gut microbiome (76).
Unfortunately, several factors limit our ability to examine the
biology of O-acetyl migration and its influence on sialic acid
foraging by bacterial populations in vivo. First, sialic acid
O-acetyl esters are extremely labile and will not survive most
processes of tissue preparation for staining or other analyses.
Second, the tools with which to monitor the placement or
movement of these glycan modifications in vivo are extremely
limited. Finally, unlike many other aspects of mammalian biology, the changes in glycan structure under study here cannot be
programmed at the genetic level. We reason that attempts to
modulate pH in vivo (analogous to what we have done for the in
vitro biochemical work shown here) would no doubt create
many pleiotropic changes in the system and thus would limit
the interpretation of the work. It may be more straightforward
(though far from trivial) to follow up on the current biochemical experiments using genetic systems in Bacteroides together
with complex co-colonization experiments in gnotobiotic
mice. Given the prior studies in humans that implicate EstA or
sialylate O-acetyl esterase activity in the healthy maturation
and dysbiosis of the gut microbiome, such work is warranted to
help evaluate whether the biochemical mechanism of EstA
described here may be acting in vivo to drive bacterial colonization and/or disease.

Experimental procedures
Bacterial strains, plasmids, and culture conditions
Strains and plasmids used in this study are described in
Table 1. LB, Circlegrow broth (MP Biomedicals), Todd
Hewitt broth (IBI Scientific), and M63 (without glucose or
glycerol) were used as bacterial growth media. For plasmid
maintenance, antibiotics were used at the following concentrations: ampicillin (Sigma), 100 g/ml; and erythromycin
(Sigma), 5 g/ml.
Accession numbers
This paper performed genetic and/or biochemical characterizations relevant to the following accession numbers: B. fragilis
NanH sialidase (WP_010992682), B. thetaiotaomicron NanH
J. Biol. Chem. (2017) 292(28) 11861–11872
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that drives the expansion of potential pathogens (31), including
E. coli. Together with these previous studies, the work presented here suggests that EstA could enable an even more
robust sialidase-dependent expansion of sialic acid scavenging
pathogens by allowing more extensive liberation of sialic acids
from the mucosa. Further investigations are warranted to
investigate the role of EstA in the intestine.
Previous studies suggest that bacterial O-acetylesterases in
the intestine may have pathologic roles in ulcerative colitis
(UC) (17, 20). Studies of fecal extracts from individuals with UC
have demonstrated that these individuals have higher levels of
sialic acid O-acetyl esterase activity compared with normal
controls, although interestingly, sialidase levels were not different between these groups (17, 20). We have noticed that among
the Bacteroides, some species appear to encode both sialidase
and esterase (e.g. B. fragilis), whereas others have only sialidase
(e.g. B. thetaiotaomicron). Thus, the finding of higher O-acetylesterase activity without higher sialidase suggests that a greater
portion of the sialidase-producing taxa present in the UC
microbiota may produce O-acetylesterases. Indeed, one recent
study cultured biopsy tissue from individuals with UC and supported the idea that there may be different spectrum of Bacteroides species in UC (65). Using an experimental approach in
mice, overgrowth of Bacteroidetes, Clostridiales, and Enterobacteriacea among other taxa was observed in a mouse model
of UC (DSS-induced colitis) (66). Taking this model one step
further, it was shown that the overpopulation by certain Bacteroides species in the DSS-induced colitis model increased sialidase activity and subsequent sialic acid-mediated outgrowth of
E. coli, which in turn led to further exacerbation of inflammation and disease (32). Finally, consistent with these studies in
mice, the overrepresentation of Enterobacteriaceae was associated with increased severity of disease in UC patients receiving
fecal transplants (67). Taken together, these findings support
the interpretation that sialic acid cross-feeding may be fueling
dysbiotic changes in the microbiota that have been linked to UC
and further highlight the potential contribution of Bacteroides
sialic acid O-acetylesterases in this process.
Recent findings in the biology of mucin synthesis, secretion,
and turnover in the distal colon illustrate a biological system in
which two layers of mucus play key roles in biology and disease.
The innermost mucus layer is firmly attached (68), turns over
rapidly (69), and typically remains free of bacteria in the healthy
colon (6). In contrast, a diverse community of microbes lives
within the outer mucus layer (70), where they produce enzymes
that facilitate the digestion and metabolism of mucin carbohydrate chains (71, 72). Sonnenburg and co-workers (2) have convincingly argued that capabilities in glycan foraging likely
evolved as part of the healthy relationship between symbiotic
bacteria and the mammalian host. Such a relationship requires
mechanisms to limit host-microbe interactions that may lead to
inflammatory or infectious disease. Within the inner mucus
layer, host proteins such as Muc2, RegIII␥, and Lydp8 exclude
bacteria from the inner mucus layer (73–75).
The data presented here suggest another mechanism by
which the carbohydrate chains of the inner mucus layer may be
protected from secreted bacterial enzymes in the gut lumen.
Specifically, 7-O-acetylation of sialic acid contributes to the
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Table 1
Strains and plasmids used in this study
Strain or plasmid

Relevant characteristics

Source/reference

E. coli MG1655
E. coli EDL933
E. coli BL21 (DE3)
E. coli C600
E. coli LSR4
B. fragilis NCTC 9343
B. thetaiotaomicron VPI-5482
S. agalactiae COH1 ⌬neuA pneuA N301A
pET101/D-Topo
pTrc99A
pLR6
pES1
pLR8

Wild-type K12 strain
Wild-type 0157:H7 strain
Expression strain
Expression strain
MG1655 ⌬nanA sialate lyase mutant
Wild-type strain
Wild-type strain
Expresses high levels of 7-O-acetylated sialic acid
Expression vector
Expression vector
B. fragilis nanH his in pET101/D
B. thetaiotaomicron nanH his in pET101/D
B. fragilis estA his in pTrc99A

Coli Genetic Stock Center
Gift from Chia Hung
New England Biolabs
Gift from Scott Hultgren
This study
DNA from this strain was a gift from Jeffrey Gordon
DNA from this strain was a gift from Jeffrey Gordon
Ref. 23
Invitrogen
Gift from Scott Hultgren
This study
This study
This study

Table 2
Primer sequences
Sequence
CACCATGAAAAAAGCCGTAATTC
TTTAATAATGTCTTTCAAC
CACCATGAAAAGAAATCATTATTTATTTACCC
TCGAATCAAATCTTTCAGTTTTAC
AAAACCATGGCAAAGAAAATTTTATTAATGATGTTGTTGCTC
TTTTGGATCCTTAGTGGTGGTGGTGGTGGTGTTTCTTATTTATATAAGGTTTAACAATATCAACC
ATAAAGGTATATCGTTTATCAGACAAGCATCACTTCAGAGGTGTAGGCTGGAGCTGCTTC
TTCCCCTCACCCGGTAGGGGCGAGCGAGGGGAAACAACTCATTCCGGGGATCCGTCGACC

sialidase (WP_008766031), B. fragilis EstA (WP_005794991),
and E. coli NanA sialic acid lyase (WP_000224714).
DNA manipulations
Primers (Integrated DNA Technologies) used in this study
are shown in Table 2. PCR products for cloning were generated
with Phusion polymerase (New England Biolabs). Restriction
endonucleases were also from NEB. The nanH genes from
B. fragilis and B. thetaiotaomicron were amplified with the
primer sets B. fragilis nanH F, B. fragilis nanH R, B. thetaiotaomicron nanH F, and B. thetaiotaomicron nanH R. PCR products
were desalted and cloned into pET101/D-Topo (Invitrogen)
according to the manufacturer’s instructions. B. fragilis estA
was amplified with B. fragilis estA F Nco and B. fragilis estA his
R Bam. The amplicon was desalted, digested with NcoI and
BamHI, and cloned into the NcoI and BamHI sites of pTrc99A.
The ⌬nanA mutation in MG1655 was made using the phage
lambda Red recombinase method (77).
Expression and purification of B. fragilis NanH-his and
B. thetaiotaomicron NanH-his
E. coli BL21(DE3) containing pES1 (B. thetaiotaomicron
nanH-his in pET101/D) or pLR6 (B. fragilis nanH-his in
pET101/D) were grown shaking in 500 ml of Circlegrow broth
at 37 °C to an A600 of ⬃1.0. Cultures were induced with 300 M
isopropyl ␤-D-thiogalactopyranoside (Gold Biotechnology) and
grown shaking overnight at room temperature. Bacteria were
pelleted at 12,000 ⫻ g, and the supernatant was passed through
a 0.22-m filter to remove any remaining cells. Then 2 ml of
His-Select nickel affinity gel slurry (Sigma) was added to the
supernatant and rotated at 4 °C for 90 min. The supernatant
was transferred to a glass column with a stopcock, and the beads
were allowed to settle over the filter. Once the supernatant was
drained, the beads were washed with 200 ml of wash buffer (50
mM NaH2PO4, pH 7.4, 300 mM NaCl, 20 mM imidazole, chem-
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icals obtained from Sigma). Sialidases were eluted in eight
150-l fractions of imidazole elution buffer (50 mM NaH2PO4,
pH 7.4, 300 mM NaCl, 250 mM imidazole). Fractions were tested
for activity with the fluorogenic sialidase substrate 4-methylumbelliferyl-N-acetylneuraminic acid (4-MU-Sia; Gold Bio). In
a black polypropylene assay plate (Eppendorf), 10 l of each
fraction was mixed with 100 l of PBS, pH 7.4, containing 100
M 4-MU-Sia. 4-Methylumbelliferone fluorescence was measured at excitation of 365 nm (bandwidth, 9 nm) and emission
of 440 nm (bandwidth, 20 nm) every 60 s in a Tecan Infinite
M200 plate reader.
Expression and purification of B. fragilis EstA
E. coli C600 containing pLR8 (B. fragilis estA-his in pTrc99A)
or pTrc99A (vector control) were grown shaking in 750 ml of
Circlegrow broth at 37 °C to an A600 of ⬃1.0 before being
induced with 100 M isopropyl ␤-D-thiogalactopyranoside.
Cultures were moved to room temperature and allowed to grow
overnight. The next day, bacteria were pelleted at 12,000 ⫻ g,
washed once in 250 ml of PBS, and resuspended in 40 ml of 50
mM Tris, pH 8.0, 10 mM EDTA, and 20% sucrose. Lysozyme
(Sigma) was added to 1 mg/ml, and the suspensions were incubated on ice for 45 min. Bacteria were pelleted, and the supernatants (containing the periplasm fraction) were transferred to
25-cm lengths of 8-kDa cutoff dialysis tubing (BioDesign).
Supernatants were dialyzed twice for 1 h at 4 °C against 1 liter of
lysis buffer (50 mM NaH2PO4, pH 7.4, 300 mM NaCl, 10 mM
imidazole), and a final time overnight at 4 °C against 1 liter of
lysis buffer. The dialyzed material was transferred to 50-ml Falcon tubes containing 700 l of His-Select nickel affinity gel
slurry, rotated for 2 h at 4 °C, then applied to 5-ml disposable
polypropylene columns (Thermo Scientific), and washed with
10 ml of wash buffer (see above). Bound proteins were then
eluted in eight 250-l fractions of imidazole elution buffer.
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Primer name
B. fragilis nanH F
B. fragilis nanH R
B. thetaiotaomicron nanH F
B. thetaiotaomicron nanH R
B. fragilis EstA F Nco
B. fragilis EstA his R Bam
nanA KO F
nanA KO R
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Sialic acid measurements
Derivatization and quantitation of sialic acids by HPLC was
carried out as previously described (56). For measurement of
total sialic acids (including bound and free), mild acetic acid
hydrolysis of samples (2 M acetic acid for 3 h at 80 °C) or
removal of sialic acids using AUS was performed prior to
derivatization with 1,2,-diamino 4,5-methylenedioxybenzene
dihydrochloride (DMB) as described below. Alternatively,
when the experimental question was the extent of sialic acid
liberation under different conditions, free sialic acid levels were
measured by DMB derivatization without prior acid hydrolysis or treatment with AUS. The samples were mixed with
2⫻ DMB reagent consisting of 14 mM DMB, 44 mM sodium
hydrosulfite, 1.5 M 2-mercaptoethanol, and 2.8 M acetic acid
and incubated at 50 °C for 2 h. Derivatized samples were
injected into a Waters HPLC equipped with a reverse-phase
C18 column (Tosoh Bioscience) and a Waters fluorescence
detector set to excite at 373 nm and detect emission at 448
nm. Peak integrations were used to quantitate sialic acid
content by referencing a standard curve of sialic acid
(Neu5Ac; Sigma) derivatized in parallel.
Sialic acid consumption assays
E. coli strains MG1655 (commensal isolate) and EDL933
(enterohemorrhagic isolate) were grown shaking in LB at 37 °C
overnight. The next day, 1 l of each stationary phase culture
was inoculated into 500 l of fresh LB. Sterile filtered Neu5Ac
(Sigma) was added to a final concentration of 100 M where
indicated. For Fig. 1C, samples were prepared similarly, but 5 l
of purified B. fragilis NanH, B. thetaiotaomicron NanH, or
commercially available V. cholerae sialidase (Sigma) was added
to 495 l of LB prior to inoculation with E. coli. Bacteria were
grown overnight as above. The following day, 100 l of each
culture was transferred to a fresh tube for acid hydrolysis and
quantification of total sialic acid by DMB HPLC. The
remaining cultures were spun at 16,000 ⫻ g for 2 min, and
supernatants were removed for quantification of free sialic
acid by DMB-HPLC.

Chemical de-O-acetylation of BSM sialic acids
O-Acetyl groups were chemically removed from BSM sialic
acids by treating samples with 100 mM NaOH for 30 min at
37 °C. Samples were then neutralized with glacial acetic acid.
Mock samples received a salt solution containing equivalent
amounts of NaOH and acetic acid used for chemical de-Oacetylation (base and acid were combined before being added to
each mock-treated sample). For the experiment presented in
Fig. 2A, base treatment was performed prior to enzyme reactions to determine how O-acetylation influenced the ability of
sialidases to liberate BSM sialic acids. To allow accurate comparison of mock-treated samples with those that were initially
de-O-acetylated, all samples were base-treated following reactions with Bacteroides sialidases.
Sialic acid release from chemically de-O-acetylated or mocktreated BSM
Bovine submaxillary mucin (Sigma) was dissolved in doubledistilled water at 10 mg/ml, and insoluble debris was removed
by centrifugation at 16,000 ⫻ g. Following base treatment
(described above), base and mock-treated samples were mixed
with NaOAc, pH 5.5, to a final BSM concentration of 2 mg/ml
and a final buffer concentration of 20 mM. Purified Bacteroides
sialidases were added at ⬃50 milliunits/ml, which was estimated using our positive control enzyme, AUS (EY Laboratories) using 4-MU-Sia as substrate as described above. The samples were incubated with enzymes at 37 °C for 5 h, followed by
NaOH treatment (and neutralization, as described above),
DMB derivatization, and HPLC. The second base treatment
was performed to allow comparison of the Neu5Ac and
Neu5Gc peaks between samples that were initially base versus mock-treated.
EstA O-acetylesterase assay using bovine submaxillary mucin
as substrate
Bovine submaxillary mucin (Sigma) was dissolved in doubledistilled water at 10 mg/ml, and insoluble debris was removed
by centrifugation at 16,000 ⫻ g. For the experiment presented
in Fig. 2C, mucin was diluted to 2 mg/ml in PBS (pH 7.4) and
mixed with a final concentration of 20 g/ml purified EstA-His
or an equivalent amount of the vector control elution (both
added at a 1/20 dilution). The samples were incubated at 37 °C
for 2 h. Bound sialic acids were then released with 250 millunits/ml AUS for 1 h at 37 °C, and DMB-HPLC was performed.
In this experiment, AUS was used in excess to enzymatically
release sialic acids quickly and to avoid using acetic acid hydrolysis of sialic acids, which itself causes some migration and loss
of O-acetyl groups (and therefore interferes with the interpretation of the experiment).
EstA-assisted release of BSM sialic acids by Bacteroides
sialidases
BSM was dissolved in water, centrifuged as above, and then
diluted to 2 mg/ml in PBS, pH 7.4, or 100 mM NaOAc, pH 5.5.
The BSM preparation was mixed with purified EstA-His at a
final concentration of 20 g/ml (or an equivalent amount of
control elution), and with purified B. fragilis or B. thetaiotaomiJ. Biol. Chem. (2017) 292(28) 11861–11872
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Purity of the eluted EstA-His6 (and control material prepared
in parallel from cells containing empty vector) was evaluated by
SDS-PAGE (on a 4 –20% gradient gel) followed by staining with
Coomassie G-250 (Bio-Rad). This revealed a single prominent
band of the expected molecular mass (23 kDa) with the highest
concentration in fraction 4 (the fraction used in our enzyme
assays; Fig. 2B). There were no evident bands in lanes loaded
with empty vector control elutions. To further verify that
this band corresponded to purified EstA, we ran a second
SDS-PAGE gel and transferred the proteins to nitrocellulose
for Western blotting with anti-His6 monoclonal antibody
(Covance). A single band at 23 kDa was recognized by the
antibody in lanes loaded with EstA-His6, but not those
loaded with vector control elutions, indicating that the purified protein is indeed EstA-His6 (Fig. 2D). Protein concentration was determined with a micro-BCA protein assay kit
(Thermo Scientific).

EstA-mediated sialic acid cross-feeding
cron NanH-His, added at ⬃50 milliunits/ml (based on estimations in comparison to AUS using 4-MU-Sia as substrate). Following incubation at 37 °C for 5 h, samples were base-treated as
described above to chemically remove O-acetyl esters prior to
DMB derivatization and HPLC, allowing an accurate quantitation of sialic acids (Fig. 2, E–H).
E. coli growth on mucin in the presence of EstA and/or
sialidases

EstA O-acetylesterase assay using sialic acids from Group B
Streptococcus as substrate
Streptococcus agalactiae, also known as GBS was used as a
model system for defining the preferences of O-acetyl placement and migration on EstA activity. Strain COH1 ⌬neuA
expressing neuA N301A from a plasmid was used because it
bears a mutated inactive version of its own sialic acid O-acetyl
esterase, which normally removes O-acetyl esters of free sialic
acids intracellularly, prior to capsule synthesis (23). The result
is that the NeuA N301A strain expresses high levels of sialic
acid O-acetylation that begins at C-7 and can be migrated to the
9-carbon position. Bacteria were grown to A600 ⫽ 0.4 in 20 ml of
Todd Hewitt broth with 5 g/ml erythromycin to maintain the
neuA N301A plasmid. The culture was divided into two
Oakridge tubes and centrifuged at 12,000 ⫻ g for 10 min. The
cells were washed three times in 100 mM NaOAc, pH 5.5. One
pellet was resuspended in 100 mM Tris, pH 9.0, and incubated at
37 °C for 30 min to migrate O-acetyl groups to the 9-carbon
position. The other pellet was resuspended in 210 l of PBS, pH
7.4, and incubated on ice. The cells in Tris were pelleted and
washed once in 1 ml of PBS and then resuspended in 210 l of
PBS. 30 l of each suspension was transferred to fresh tubes for
0⬘ time points. 90-l aliquots of the remaining suspensions
were mixed either with 10 l of purified EstA (for a final concentration of 40 g/ml) or an equivalent volume of vector control elution. The four mixes were then divided into three tubes
each of 30 l and incubated for 30, 90, or 300 min at 37 °C. At
each time point, the cells were pelleted and washed with 1 ml of
100 mM NaOAc, pH 5.5. Bacteria were resuspended in 30 l of
20 mM NaOAc, pH 5.5, containing 250 milliunits/ml AUS and
incubated for 1 h at 37 °C. The cells were pelleted, and 20 l of
supernatant was removed and diluted 4⫻ in double-distilled
water prior to DMB derivatization and HPLC.
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